Found: 8
Select item for more details and to access through your institution.
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2022, v. 11, n. 3, p. 328, doi. 10.1089/jayao.2021.0103
- By:
- Publication type:
- Article
AI-Radiomics Can Improve Inclusion Criteria and Clinical Trial Performance.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 1, p. 341, doi. 10.3390/tomography8010028
- By:
- Publication type:
- Article
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1532, doi. 10.1002/cam4.5044
- By:
- Publication type:
- Article
Clinical trial enrollment of adolescents and young adults with sarcoma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3434, doi. 10.1002/cncr.30757
- By:
- Publication type:
- Article
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 453, doi. 10.1093/oncolo/oyac272
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1655, doi. 10.1634/theoncologist.2020-0679
- By:
- Publication type:
- Article